ABIN121153
antibody from antibodies-online
Targeting: CEBPB
C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN121153 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 1-271), (N-Term) antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant human C/EBP-beta (1-271 aa) purified from E. coli
- Description
- Protein-G affinity chromatography
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-271,N-Term
- Isotype
- IgG
- Antibody clone number
- 47A1
- Vial size
- 0.1 mL
- Concentration
- 1.0 mg/mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf Life: one year from despatch.
Submitted references Differential activation of a C/EBP beta isoform by a novel redox switch may confer the lipopolysaccharide-inducible expression of interleukin-6 gene.
Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP).
Biological role of the CCAAT/enhancer-binding protein family of transcription factors.
Su WC, Chou HY, Chang CJ, Lee YM, Chen WH, Huang KH, Lee MY, Lee SC
The Journal of biological chemistry 2003 Dec 19;278(51):51150-8
The Journal of biological chemistry 2003 Dec 19;278(51):51150-8
Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP).
Parkin SE, Baer M, Copeland TD, Schwartz RC, Johnson PF
The Journal of biological chemistry 2002 Jun 28;277(26):23563-72
The Journal of biological chemistry 2002 Jun 28;277(26):23563-72
Biological role of the CCAAT/enhancer-binding protein family of transcription factors.
Lekstrom-Himes J, Xanthopoulos KG
The Journal of biological chemistry 1998 Oct 30;273(44):28545-8
The Journal of biological chemistry 1998 Oct 30;273(44):28545-8
No comments: Submit comment
No validations: Submit validation data